A significant advance in cancer research is arising with the use of nanobodies to reactivate mutated p53. This essential cancer inhibitor protein is frequently disabled in several types of tumors, causing uncontrolled https://yoursocialpeople.com/story7443977/mini-antibodies-reactivate-tumor-suppressor-p53-a-promising-approach-for-cancer-management